Jump to search

May 2020

Pilot study to assess intranasal compound for prevention of SARS-CoV-2 infection

May 20, 2020

Can an antiviral compound found in shellfish be effective against the novel coronavirus? The Covid Catalyst Fund awarded a grant to conduct a rule-out study.

Depression symptoms linked to reduced cognitive control in people with autism

May 19, 2020

Symptoms of depression in young adults with autism were linked to less proactive cognitive control, a new UC Davis MIND Institute study has found.

UC Davis Health identifies biomarker for early blood vessel damage due to sickle cell anemia

May 15, 2020

Unique computer-assisted microscope offers non-invasive, real-time approach to assess blood vessels

UC Davis researchers get $3 million FAST grant to find treatment for Angelman syndrome

May 14, 2020

Two UC Davis researchers receive $3 million grant to find an effective treatment for Angelman syndrome, a rare neurodevelopmental disorder.

Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?

May 12, 2020

UC Davis scientists provide senicapoc for COVID-19 clinical trial in Denmark.

Access to primary care differs by county for Medi-Cal patients

May 11, 2020

New research from UC Davis Health policy experts shows that Medi-Cal patients in Yolo County have better access to primary care than patients in nearby counties. Primary care access was worse in Sacramento, San Joaquin and Solano counties. 

New insight on maternal infections and neurodevelopmental disorders

May 5, 2020

The immune responses of a female mouse before pregnancy can predict how likely her offspring are to have behavioral deficits if the immune system is activated during pregnancy, according to researchers from the Center for Neuroscience at UC Davis. The findings, published in the journal Brain, Behavior, and Immunity, could help resolve what role serious infections during pregnancy play in the later development of conditions such as autism and schizophrenia in offspring.

April 2020

UC Davis engineers, clinician develop low-cost, portable ventilator

April 29, 2020

UC Davis engineers and clinicians are working to create a simple, inexpensive ventilator. They have developed a prototype and plan to make plans freely available online. Versions could be inclinical use in about six months.

UC Davis expert panel weighs in on COVID-19 research, response and readiness in the U.S.

April 29, 2020

Experts in immunology, infectious diseases, pathology and emergency medicine presented the latest research and insights on COVID-19 in an online symposium.

COVID-19 vaccine with patch delivery technology enters preclinical testing at UC Davis

April 29, 2020

A biopharmaceutical company will begin preclinical testing, in collaboration with UC Davis, to evaluate the potential for COVID-19 vaccine delivered through an innovative skin patch.

Arteries respond in opposite ways for males and females

April 23, 2020

A protein known to expand blood vessels — key to controlling conditions like high blood pressure — actually has different functions in males and females. 

Behavioral intervention, not lovastatin, improves language skills in youth with fragile X

April 22, 2020

A UC Davis Health study found more evidence for the efficacy of behavioral intervention in treating language problems in youth with fragile X syndrome (FXS), but not for lovastatin as a treatment for FXS.

Diana Miglioretti honored with national award for her translational work on breast cancer screening

April 17, 2020

Biostatistics professor receives Distinguished Investigator Award for her work on improving breast cancer screening.

Remdesivir improved majority of patients hospitalized with severe COVID-19

April 16, 2020

Preliminary results of the first 53 patients who received the promising antiviral remdesivir on a compassionate-use basis were published in the New England Journal of Medicine. UC Davis Health was among the select group of hospitals that participated in the unprecedented international study.

‘Sick posts’ on social media help early tracking of COVID-19

April 16, 2020

Tracking social media “sick posts” could give public health officials a head start on identifying and responding to emerging disease outbreaks, researchers at the University of California, Davis, suggest in a new working paper.

Computer model predicts how drugs affect heart rhythm

April 10, 2020

UC Davis Health researchers have developed a computer model to screen drugs for unintended cardiac side effects, especially arrhythmia risk.

California Smokers’ Helpline offers free nicotine patches

April 9, 2020

Callers to the California Smokers’ Helpline can now get an additional tool to help them quit using tobacco: nicotine patches.

Mind-body medicine experts urge full integration of stress reduction into care and research

April 8, 2020

In a perspective published in the New England Journal of Medicine, researchers from the Benson-Henry Institute for Mind Body Medicine and UC Davis Health call for broader use of mind-body practices. 

New surgical technique prevents stoma complications after appendicostomy

April 7, 2020

The risk of stoma complications after appendicostomy can be significantly lowered by a new surgical procedure.

Award supports cutting-edge biomedical research to benefit children with cerebral palsy

April 6, 2020

Lucas Smith receives prestigious 2019 Hartwell Individual Biomedical Research Award for his innovative cutting-edge biomedical research benefiting children with cerebral palsy.

How important is speech in transmitting coronavirus?

April 2, 2020

Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis. 

March 2020

What the blood tests of a COVID-19 patient can tell us

March 31, 2020

A blood test result typically seen in bone marrow diseases was found in a patient with COVID-19.

Solving a medical mystery and changing CDC screenings for COVID-19

March 30, 2020

UC Davis Health physicians and medical staff detail the diagnosis and treatment for first known case of community transmission of COVID-19 in the U.S.

UC Davis launches two clinical studies to treat COVID-19

March 26, 2020

Hospitalized patients with severe COVID-19 infection may be enrolled in clinical studies evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.

Coronavirus in children: Observations from Wuhan, China

March 26, 2020

New research from Wuhan, China provide insights on the manifestations of coronavirus infection in children.

Five language outcome measures evaluated for intellectual disabilities studies

March 25, 2020

Expressive language sampling addresses urgent need in fragile X syndrome research and therapy.

Home-based video visits improve glycemic control among pediatric type 1 diabetes patients

March 23, 2020

Can remote video visits help improve glycemic control and clinic attendance for children and adolescents with type 1 diabetes?

UC Davis researchers race to develop coronavirus solutions

March 20, 2020

UC Davis clinical pathologists, infectious disease physicians and scientists are collaborating on new reagents, diagnostic tests and a vaccine for the COVID-19 coronavirus.

Wearable device assists people with loss of bladder function

March 13, 2020

Researchers at UC Davis are designing a wearable device to help patients with spinal cord injury recognize bladder fullness.

Report highlights the need for integrated services for the chronically homeless

March 11, 2020

Recommendations for meeting the needs of Sacramento's unsheltered population are presented in “Integrating Care for People Experiencing Homelessness.” 

Felons have high gun ownership rates despite prohibitions

March 10, 2020

There is a substantial population of firearm owners in California and likely across the U.S. who have retained their guns even after being involved in events that prohibited them from ownership, a UC Davis Violence Prevention Research Program study has found.

24 UC Davis School of Medicine researchers ranked in top 10% for NIH funding

March 9, 2020

24 researchers from UC Davis School of Medicine ranked in the top 10% in their fields for 2019 NIH funding, according to Blue Ridge rankings. Nine departments ranked in the top 20 nationally.

Poster Day featured more than 100 studies by medical school students

March 5, 2020

Record number of participants at Poster Day

New study aims to reduce osteoarthritis after injury

March 3, 2020

Researcher Blaine Christiansen will receive $2.3 million from the National Institutes of Health to determine the ideal balance of exercise and rest for injured joints.